SenesTech Inc (SNES) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of SenesTech Inc stock $1.28, price $1.11, upside +15.8%, quality 38 out of 100. Rating: undervalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range $0.6290 – $4,320 · fair‑value band $0.8400 – $1.60 · the $1.11 price screens below the $1.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow SenesTech in your weekly email
Every Wednesday you see whether SenesTech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
Show moreShow less
The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption.
It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
Stock analysis
SenesTech Inc (SNES) currently trades at $1.11, while our model-based Fair Value estimate is $1.28, implying the stock looks roughly 14% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: $0.8400 (bear) to $1.60 (bull), the price of $1.11 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
SenesTech Inc reported revenue of $2.2M in FY2025 versus $576K in FY2021, a compound +40.1%/yr. Reported net income was −$6.4M in FY2025.
Key figures
Market cap $5.9M Micro · P/S ratio 1.56 · EPS (TTM) $−1.22 · Return on equity −107% · Return on assets (EBIT) −114% (5-year average) · Operating margin −242% · Revenue (TTM) $2.4M · Revenue growth (YoY) +23.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).
What moves the price
The share trades about 68% below its 52-week high and 76% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at 16%, SNES screens cheaper than that median.
Fair Value models
Bear$0.8400Fair Value $1.28Bull$1.60
Price $1.11 · Upside +15.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, one officer or director bought shares worth $13,070, on Sep 28, 2026.
BuyGLENBROOK CAPITAL MANAGEMENT10% owner16× since Jan 30, 2026: 1,651,346 shares, avg. $1.09$1.8MOct 30, 2026
BuyMichael EdellChief Executive Officer, Director7× since May 14, 2026: 11,000 shares, avg. $1.19$13,070Sep 28, 2026
SaleJacob Steven LeachDirector62 shares at $2.71$168Nov 18, 2025
SaleMatthew K SzotDirector1 shares at $2.75$3Nov 14, 2025
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+19.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+53.8%
Start year 2020 (pandemic). Over 10 years: +24.9% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.5%
’14
’15
’16
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−3,074.8% (2020) → −292.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
News mood ⓘNews mood, the average tone of recent news (33 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks
Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside+15.8% · Above median
Profitability
Return on assets−49.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)23.2% · Above median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "SenesTech Inc Fair Value". https://www.fairvalue-calculator.com/stock/SNES
Frequently asked questions
Is SenesTech Inc (SNES) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $1.28 versus a price of $1.11, about +16% upside (undervalued).
What is the fair value of SNES?
Our model-based fair value for SenesTech Inc is $1.28 (as of Nov 7, 2026), built from audited fundamentals. The current price: $1.11.
What is the quality score of SNES?
SenesTech Inc has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SenesTech Inc (SNES)?
Our model-based price target is the fair value of $1.28 (as of Nov 7, 2026) from 1 valuation models. Cautious scenario $0.8400, optimistic scenario $1.60. It is a calculation from audited fundamentals, not an analyst target.
What is the SenesTech Inc stock forecast for 2026?
Our models put fair value at $1.28, about +16% upside versus a price of $1.11 (undervalued). Cautious scenario $0.8400, optimistic scenario $1.60. The calculation is refreshed regularly with new filings.
What is the revenue of SenesTech Inc (SNES)?
SenesTech Inc reported trailing-twelve-month revenue of about $2.4M (latest available figure, as of Nov 7, 2026).
What is the intrinsic value of SenesTech Inc (SNES)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SenesTech Inc it is $1.28 per share (as of Nov 7, 2026), against a price of $1.11. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is SenesTech Inc stock overvalued or undervalued in 2026?
As of Nov 7, 2026, SNES trades below its calculated fair value: price $1.11, fair value $1.28, a gap of about +16% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SNES?
No. The price is what the market pays today ($1.11); the fair value is what the company's own numbers justify ($1.28). For SenesTech Inc the two are $0.1750 per share apart. That gap is exactly why we show both numbers side by side.
How much is SenesTech Inc worth?
The market values SenesTech Inc at about $5.9M (market capitalisation, as of Nov 7, 2026). Per share that is $1.11; our models calculate a fair value of $1.28 per share.
What do the bullish and bearish scenarios say about SNES?
Our models span a range for SenesTech Inc: cautious scenario $0.8400, base $1.28, optimistic $1.60 per share (as of Nov 7, 2026, price $1.11). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SenesTech Inc (SNES)?
Balance-sheet figures for SenesTech Inc (as of Nov 7, 2026): return on equity −107.4%, debt of 0.02 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is SNES from its 52-week high?
SenesTech Inc trades at $1.11, about 68% below its 52-week high of $3.48 and 76% above the low of $0.6290 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $1.28 is for.
Which stocks are comparable to SenesTech Inc?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SenesTech Inc stock attractive at the current price?
The data as of Nov 7, 2026: price $1.11, calculated fair value $1.28 (+16%), Quality Score 38/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SNES calculated?
We run SenesTech Inc through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $1.28 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. SenesTech Inc currently trades 14% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SenesTech Inc (SNES)?
The closing price on Nov 6, 2026 was $1.11. Our model-based fair value is $1.28, about +16% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SenesTech Inc right now?
A fairly wide model range ($0.8400 to $1.60) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of SenesTech Inc
How large is the market capitalisation of SenesTech Inc (SNES)?
The market capitalisation of SenesTech Inc is $5.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SenesTech Inc (SNES)?
The price-to-sales ratio of SenesTech Inc is 1.56 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of SenesTech Inc (SNES)?
Earnings per share at SenesTech Inc are $−1.22. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of SenesTech Inc (SNES)?
The return on equity (ROE) of SenesTech Inc is −107% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SenesTech Inc (SNES)?
On an EBIT basis the return on assets of SenesTech Inc is −114% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SenesTech Inc (SNES)?
The operating margin of SenesTech Inc is −242% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SenesTech Inc (SNES)?
Revenue at SenesTech Inc is growing +23.2% versus a year earlier (3y avg +29.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does SenesTech Inc (SNES) generate?
The free cash flow of SenesTech Inc is −$5.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does SenesTech Inc (SNES) hold?
SenesTech Inc holds more cash than debt, $4.9M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch SenesTech Inc in the live analysis
One click puts SenesTech Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026
